Molecular Basis and Novel Treatment of Epilepsy
A special issue of Biomolecules (ISSN 2218-273X).
Deadline for manuscript submissions: 15 December 2024 | Viewed by 84
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue of Biomolecules focuses on the molecular mechanisms that contribute to epilepsy and the development of novel treatments. Epilepsy is a neurological disorder that manifests as seizures and is one of the leading global health burdens. Although there is continuous development of anti-seizure drugs, one-third of patients remain refractory. Therefore, there is an urgent need to identify novel molecular targets for the future development of new treatments for epilepsy. This Special Issue will present up-to-date reviews and original research articles on the genetic basis of human epilepsy, molecular mechanisms of epileptogenesis, and translational research on novel treatments for epilepsy.
Dr. Fang Zheng
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- epilepsy
- genetic basis
- epileptogenesis
- antiseizure drugs
- novel treatment
- translational research
